Chemical and Pharmaceutical Bulletin · 2002 · 14 citations · 15 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug MetabolismMolecular PharmacologyCholinergic PharmacologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug-metabolizing EnzymesNeurochemical PharmacologyBiomimetic OxidationCytochrome EnzymesCytochrome P450 Drug MetabolismCytochrome P450 Enzyme ActivityCytochrome P450 Reaction MechanismsCytochrome SystemsMuscarinic Receptor AntagonismMuscarinic Receptor Pharmacology
A chemical model system for cytochrome P-450, consisting of tetraphenylporphyrin manganese chloride (TPPMnCl) and iodosylbenzene, efficiently oxidized 2-methylimidazole to 2-methylimidazolone. This system was next applied to 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutyramide, a muscarinic acetylcholine receptor antagonist under clinical trial, affording the previously unisolated imidazole ring 5-mono-oxidized derivative that is considered to be the precursor of the main metabolites. This system, which is superior to the copper-ascorbate system, should be applicable to in vitro studies of various drugs containing the 2-methylimidazole moiety.
15
James P. Collman, John I. Brauman, Bernard Meunier et al. · Journal of the American Chemical Society · 1985 · 175 citations
P. N. Balasubramanian, Ashoke Sinha, Thomas C. Bruice · Journal of the American Chemical Society · 1987 · 80 citations